Literature DB >> 23851934

suPAR and FSGS: the gap between bench and bedside.

Maarten Naesens, Björn Meijers, Ben Sprangers.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23851934     DOI: 10.1097/TP.0b013e31829e6d40

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

Review 1.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

2.  Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children.

Authors:  Zhaoyang Peng; Jianhua Mao; Xuejun Chen; Fengqing Cai; Weizhong Gu; Haidong Fu; Huijun Shen; Jingjing Wang; Xia Jin; Xiujuan Zhu; Aimin Liu; Qiang Shu; Lizhong Du
Journal:  Pediatr Nephrol       Date:  2014-07-18       Impact factor: 3.714

3.  Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis.

Authors:  Claudio Musetti; Marco Quaglia; Tiziana Cena; Annalisa Chiocchetti; Sara Monti; Nausicaa Clemente; Corrado Magnani; Umberto Dianzani; Piero Stratta
Journal:  J Nephrol       Date:  2014-09-04       Impact factor: 3.902

Review 4.  Permeability factors in focal and segmental glomerulosclerosis.

Authors:  Jochen Reiser; Cynthia C Nast; Nada Alachkar
Journal:  Adv Chronic Kidney Dis       Date:  2014-09       Impact factor: 3.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.